Repeated mild traumatic brain injury causes persistent changes in histone deacetylase function in hippocampus: Implications in learning and memory deficits in rats

• Published in: Brain research Vol. 1711; pp. 183 - 192
• Main Authors: Sagarkar, Sneha, Balasubramanian, Nagalakshmi, Mishra, Shruti, Choudhary, Amit G., Kokare, Dadasaheb M., Sakharkar, Amul J.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.05.2019
• Subjects: Cocaine- and amphetamine-regulated transcript peptide; HDAC inhibitors; Hippocampus; Learning and memory; Mild traumatic brain injury; NOR; Learning and memory; MWM; TSA; DG; Mild traumatic brain injury; DI; rMTBI; Cocaine- and amphetamine-regulated transcript peptide; HDAC inhibitors; CARTp; Hippocampus
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/j.brainres.2019.01.022

•Repeated mild traumatic brain injury (rMTBI) compromised learning and memory.•rMTBI persistently altered HDAC function in hippocampus.•rMTBI impaired histone acetylation at CART promoter and CART expression.•HDAC inhibitor restored rMTBI-induced deficits in histone acetylation.•The study implicates HDAC in cognitive deficits post trauma, likely via CART gene regulation. Impaired attention and memory represent some of the major long-term consequences of brain injuries. However, little is known about the underlying molecular mechanisms of brain trauma-induced cognitive decline. Histone deacetylases (HDACs) in the hippocampus are believed to impact learning and memory. Herein, we have induced repeated mild traumatic brain injury (rMTBI) in rats by using weight-drop paradigm, examined the recognition memory using novel object recognition task, and assessed the HDAC activities in the hippocampus post 48 h and 30 days of rMTBI. The recognition memory was significantly compromised in the rMTBI-exposed rats at both the time points. The rMTBI increased mRNA levels of different isoforms of HDACs (HDAC2-5 and HDAC11) at different time points coupled with rise in nuclear and cytosolic HDAC activities. However, a mild decrease in HDAC8 mRNA levels was observed at 30 days time point. As a corollary, rMTBI also caused persistent decrease in the levels of acetylated histone H3-Lys 9 (H3-K9ac) in promoter region of cocaine- and amphetamine-regulated transcript (CART) gene with concurrent decline in CART mRNA and peptide (CARTp) levels. Furthermore, the treatment with trichostatin A (TSA), a pan HDAC inhibitor, restored the rMTBI-induced deficits in recognition memory and HDAC activities with commensurate changes in the H3-K9ac and CART mRNA levels. Together, these results suggest that rMTBI may trigger persistent changes in HDAC-mediated histone acetylation at the CART gene promoter culminating into deficits in learning and memory. Further, the present study also identifies therapeutic potential of HDAC inhibitors in rescuing MTBI-induced cognitive deficits.